$ANKM
Ankam, Inc.

2024 Q3 Form 10-Q Financial Statement

#000168316824007147 Filed on October 15, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2023 Q4 2023 Q3
Revenue $8.697K $7.480K $5.999K
YoY Change 44.97%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin -$93.28K
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $24.94K
YoY Change
% of Gross Profit
Operating Expenses $79.10K -$89.27K $75.00K
YoY Change 5.46% 753.87%
Operating Profit -$70.40K -$69.01K
YoY Change 2.03%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $44.93K -$179.2K $44.90K
YoY Change 0.06%
Pretax Income $83.91K -$63.60K -$69.01K
YoY Change -221.59% 685.58%
Income Tax $0.00
% Of Pretax Income 0.0%
Net Earnings $83.91K -$63.60K -$69.01K
YoY Change -221.59% 685.58%
Net Earnings / Revenue 964.76% -850.27% -1150.28%
Basic Earnings Per Share $0.01 -$0.02
Diluted Earnings Per Share $0.01 -$0.01 -$0.02
COMMON SHARES
Basic Shares Outstanding 4.328M shares 4.328M shares 4.328M shares
Diluted Shares Outstanding 4.558M shares 4.328M shares

Balance Sheet

Concept 2024 Q3 2023 Q4 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $290.00
YoY Change
Cash & Equivalents $19.19K $286.00 $355.00
Short-Term Investments
Other Short-Term Assets $64.49K
YoY Change
Inventory
Prepaid Expenses $30.00K $15.85K $20.10K
Receivables $0.00 $21.39K
Other Receivables $0.00
Total Short-Term Assets $59.74K $86.17K $55.51K
YoY Change 7.62% -51.27% 1237.32%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $0.00
YoY Change
Total Long-Term Assets $117.7K $22.16K $248.3K
YoY Change -52.59% -91.77% 16.95%
TOTAL ASSETS
Total Short-Term Assets $59.74K $86.17K $55.51K
Total Long-Term Assets $117.7K $22.16K $248.3K
Total Assets $177.4K $108.3K $303.8K
YoY Change -41.59% -75.71% 40.36%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $84.00K
YoY Change
Accrued Expenses $44.90K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $292.0K
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $471.3K $433.6K $565.5K
YoY Change -16.65% -11.9% 143.03%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $471.3K $433.6K $565.5K
Total Long-Term Liabilities $0.00
Total Liabilities $471.3K $433.6K $565.5K
YoY Change -16.65% -11.9% 143.03%
SHAREHOLDERS EQUITY
Retained Earnings -$467.5K -$360.9K $297.3K
YoY Change -257.26% -541.53% 473.44%
Common Stock $4.558K $4.328K $4.328K
YoY Change 5.31% 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$293.9K -$325.3K -$261.7K
YoY Change
Total Liabilities & Shareholders Equity $177.4K $108.3K $303.8K
YoY Change -41.59% -75.71% 40.36%

Cashflow Statement

Concept 2024 Q3 2023 Q4 2023 Q3
OPERATING ACTIVITIES
Net Income $83.91K -$63.60K -$69.01K
YoY Change -221.59% 685.58%
Depreciation, Depletion And Amortization $24.94K
YoY Change
Cash From Operating Activities -$320.4K
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $241.4K
YoY Change
Cash From Investing Activities $241.4K
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 77.01K
YoY Change
NET CHANGE
Cash From Operating Activities -320.4K
Cash From Investing Activities 241.4K
Cash From Financing Activities 77.01K
Net Change In Cash -1.990K
YoY Change
FREE CASH FLOW
Cash From Operating Activities -$320.4K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Type
DocumentType
10-Q
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-69005 usd
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--11-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0001781629
CY2024Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-08-31
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-56526
dei Entity Registrant Name
EntityRegistrantName
ANKAM, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
61-1900749
dei Entity Address Address Line1
EntityAddressAddressLine1
5F., No. 97,
dei Entity Address Address Line2
EntityAddressAddressLine2
Jingye 1st Rd.,
dei Entity Address Address Line3
EntityAddressAddressLine3
Zhongshan Dist.,
dei Entity Address City Or Town
EntityAddressCityOrTown
Taipei City
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
104
dei Entity Address Country
EntityAddressCountry
TW
dei City Area Code
CityAreaCode
886
dei Local Phone Number
LocalPhoneNumber
928486237
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
No
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
4558063 shares
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
19185 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
286 usd
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
0 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
21390 usd
CY2024Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
30000 usd
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
15847 usd
CY2024Q3 ankm Operating Lease Right Of Use Asset Current
OperatingLeaseRightOfUseAssetCurrent
10559 usd
CY2023Q4 ankm Operating Lease Right Of Use Asset Current
OperatingLeaseRightOfUseAssetCurrent
48643 usd
CY2024Q3 us-gaap Assets Current
AssetsCurrent
59744 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
86166 usd
CY2024Q3 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
117695 usd
CY2023Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
22157 usd
CY2024Q3 us-gaap Assets
Assets
177439 usd
CY2023Q4 us-gaap Assets
Assets
108323 usd
CY2024Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
2000 usd
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
84000 usd
CY2024Q3 us-gaap Deferred Revenue
DeferredRevenue
20000 usd
CY2023Q4 us-gaap Deferred Revenue
DeferredRevenue
12700 usd
CY2024Q3 ankm Related Party Loan
RelatedPartyLoan
449338 usd
CY2023Q4 ankm Related Party Loan
RelatedPartyLoan
292026 usd
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
0 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
44900 usd
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
471338 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
433626 usd
CY2024Q3 us-gaap Liabilities
Liabilities
471338 usd
CY2023Q4 us-gaap Liabilities
Liabilities
433626 usd
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4558063 shares
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
4558 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
4328 usd
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
169072 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
31262 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-467529 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-360893 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-293899 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-325303 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
177439 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
108323 usd
CY2024Q3 us-gaap Revenues
Revenues
8697 usd
CY2023Q3 us-gaap Revenues
Revenues
5999 usd
us-gaap Revenues
Revenues
33842 usd
us-gaap Revenues
Revenues
19697 usd
CY2024Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
63 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4139 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
26884 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
306 usd
CY2024Q3 us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
16000 usd
CY2023Q3 us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
18000 usd
us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
62000 usd
us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
54000 usd
CY2024Q3 us-gaap Professional Fees
ProfessionalFees
4942 usd
CY2023Q3 us-gaap Professional Fees
ProfessionalFees
4989 usd
us-gaap Professional Fees
ProfessionalFees
35320 usd
us-gaap Professional Fees
ProfessionalFees
25322 usd
CY2024Q3 us-gaap Other Expenses
OtherExpenses
44925 usd
CY2023Q3 us-gaap Other Expenses
OtherExpenses
44898 usd
us-gaap Other Expenses
OtherExpenses
134721 usd
us-gaap Other Expenses
OtherExpenses
134694 usd
CY2024Q3 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
13170 usd
CY2023Q3 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
6978 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
35861 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
20933 usd
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
79098 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
75004 usd
us-gaap Operating Expenses
OperatingExpenses
294785 usd
us-gaap Operating Expenses
OperatingExpenses
235255 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-70403 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-69005 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-260944 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-215558 usd
CY2024Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
154308 usd
CY2023Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
154308 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
83905 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-106636 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-215558 usd
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
83905 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-69005 usd
us-gaap Net Income Loss
NetIncomeLoss
-106636 usd
us-gaap Net Income Loss
NetIncomeLoss
-215558 usd
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.02
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.02
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.05
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.05
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4558063 shares
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4558063 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4327996 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4327996 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4558063 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4558063 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4327996 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4327996 shares
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-46146 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-81677 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-127823 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-64876 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-192699 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-69005 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-261704 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-325303 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-118713 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-444016 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-71828 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-515844 usd
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Mark To Market
AdjustmentsToAdditionalPaidInCapitalMarkToMarket
138040 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
83905 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-293899 usd
us-gaap Net Income Loss
NetIncomeLoss
-106636 usd
us-gaap Net Income Loss
NetIncomeLoss
-215558 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
35861 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
20933 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-21390 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-4800 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
14153 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
20099 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-38084 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-7919 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-82000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-40324 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
7300 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
5057 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-44900 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
0 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-145054 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-237272 usd
us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
131399 usd
us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
-0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-131399 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
157312 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
235350 usd
ankm Proceeds From Issuance Of Additional Paid In Common Stock
ProceedsFromIssuanceOfAdditionalPaidInCommonStock
230 usd
ankm Proceeds From Issuance Of Additional Paid In Common Stock
ProceedsFromIssuanceOfAdditionalPaidInCommonStock
0 usd
ankm Proceed From Issuance Of Additional Paid In Capital
ProceedFromIssuanceOfAdditionalPaidInCapital
137810 usd
ankm Proceed From Issuance Of Additional Paid In Capital
ProceedFromIssuanceOfAdditionalPaidInCapital
0 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
295352 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
235350 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
18899 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1922 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
286 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2277 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
19185 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
355 usd
us-gaap Interest Paid
InterestPaid
0 usd
us-gaap Interest Paid
InterestPaid
0 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
us-gaap Revenue Recognition Revenue Reductions
RevenueRecognitionRevenueReductions
<p id="xdx_845_eus-gaap--RevenueRecognitionRevenueReductions_z0cEtd7vss5k" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="text-decoration: underline"><span id="xdx_86A_z7K4FMVuLK0d">Revenue Recognition</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company offers a newsletter subscription, which contains the most significant news in the cryptocurrency market. In most cases identified articles show price changes, experts’ opinions, technical information that can be used to understand the market and make decisions in this area.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company recognizes revenue in accordance with Accounting Standards Update (“ASU”) No. 2014-09, <i>"Revenue from Contracts with Customer"</i>. The Company applies the following five steps in order to determine the appropriate amount of revenue to be recognized as it fulfills its obligations under each of its agreements:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Step 1: Identify the contract with a customer</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Step 2: Identify the performance obligations in the contract</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Step 3: Determine the transaction price</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Step 4: Allocate the transaction price to the performance obligations in the contract</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Step 5: Recognize revenue when (or as) the entity satisfies a performance obligation</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company recognizes revenue when the customer obtains control of the good or service through the Company satisfying a performance obligation by transferring the promised good or service to the customer. The revenue is recognized on a straight-line basis from the date the subscription is sold.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Company collects payment from customers before the service is provided. When deposits are collected before the service is provided, the Company recognizes deferred revenue.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2024Q3 us-gaap Allowance For Doubtful Accounts Premiums And Other Receivables
AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables
0 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Premiums And Other Receivables
AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables
0 usd
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_84B_eus-gaap--UseOfEstimates_zDv6obutITFf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="text-decoration: underline"><span id="xdx_86C_zlp0EqbxCXIf">Use of Estimates</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>
us-gaap Dilutive Securities
DilutiveSecurities
0 usd
us-gaap Dilutive Securities
DilutiveSecurities
0 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
134721 usd
CY2023 us-gaap Operating Lease Expense
OperatingLeaseExpense
53144 usd
CY2024Q3 ankm Operating Lease Right Of Use Asset Gross
OperatingLeaseRightOfUseAssetGross
51052 usd
CY2023Q4 ankm Operating Lease Right Of Use Asset Gross
OperatingLeaseRightOfUseAssetGross
51052 usd
CY2024Q3 ankm Operating Lease Right Of Use Asset Accumulated Amortization
OperatingLeaseRightOfUseAssetAccumulatedAmortization
-40493 usd
CY2023Q4 ankm Operating Lease Right Of Use Asset Accumulated Amortization
OperatingLeaseRightOfUseAssetAccumulatedAmortization
-2409 usd
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
10559 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
48643 usd
CY2024Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
0 usd
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
44900 usd
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
0 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
44900 usd
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
0 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
0 usd
CY2024Q3 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
158045 usd
CY2023Q4 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
26645 usd
CY2024Q3 us-gaap Capitalized Computer Software Accumulated Amortization
CapitalizedComputerSoftwareAccumulatedAmortization
40349 usd
CY2023Q4 us-gaap Capitalized Computer Software Accumulated Amortization
CapitalizedComputerSoftwareAccumulatedAmortization
4488 usd
CY2024Q3 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
117695 usd
CY2023Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
22157 usd
CY2024Q3 us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
13170 usd
CY2023Q3 us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
6978 usd
us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
35861 usd
us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
20933 usd
us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
467529 usd
CY2023 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
360893 usd
us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
467529 usd
CY2023 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
360893 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2024Q3 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
98181 usd
CY2023Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
75787 usd
CY2024Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
98181 usd
CY2023Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
75787 usd
CY2024Q3 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 usd
CY2023Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 usd
CY2024Q3 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
467529 usd
CY2024Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001683168-24-007147-index-headers.html Edgar Link pending
0001683168-24-007147-index.html Edgar Link pending
0001683168-24-007147.txt Edgar Link pending
0001683168-24-007147-xbrl.zip Edgar Link pending
ankam_ex3100.htm Edgar Link pending
ankam_ex3200.htm Edgar Link pending
ankam_i10q-083124.htm Edgar Link pending
ankm-20240831.xsd Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
ankm-20240831_def.xml Edgar Link unprocessable
ankm-20240831_cal.xml Edgar Link unprocessable
ankm-20240831_lab.xml Edgar Link unprocessable
ankm-20240831_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
ankam_i10q-083124_htm.xml Edgar Link completed